Bank-sold life insurance policies tend to end earlier than agency policies, and the sale is often the reason. This preprint studies that question end to end on a fully synthetic portfolio of 32,000 policies issued between 2022 and 2025 through eight fictitious partner banks, an agency force and a digital channel, built from nine linked tables with known planted effects and documented leakage traps. RQ1 measures the gap in early exit between bank-sold and agency policies, shows that product mix does not explain it, assigns it with an exact model-based bookkeeping to the customer base, to observable sale conditions (a loan around the sale, selling in the last week of a quarter, a deposit-only customer buying a single premium, a premium large against the deposit balance) and to an unexplained channel residual, and measures how little of the variation lies with partners, branches and sellers using a multilevel logistic model. RQ2 predicts exit from signals available 60 days after issue, comparing an Explainable Boosting Machine with logistic regression and gradient boosting on a later cohort, with leakage-safe unit track records, ablations, calibration and temporal robustness. RQ3 builds shrunk scorecards with funnel-plot limits for branches and sellers, validates them against the planted truth, derives a call-back rule that weighs the value at stake rather than risk alone, and sizes the randomised pilot needed to measure the save probability. All data are synthetic: no data from IFG Life or any other insurer or bank were used, and no result is a finding about a real company. The archive contains the paper, the data with a data dictionary and ground-truth files, the code, a Jupyter notebook and the results, and regenerates every number in the paper with one script.
No takes yet. Share an insight, caveat, or question.
Marcus Carpenter (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: